Marksans Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 08, 2025
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has notified its 33rd AGM scheduled for Friday, August 8, 2025 at 9:00 AM, to be conducted via video conferencing. Key ordinary business items include adopting audited standalone and consolidated financial statements for FY25 and declaring a dividend of ₹0.80 per equity share (80% on face value of ₹1), with a record date of August 1, 2025 and payment from August 21, 2025. Special business includes the appointment of Srinivas Mishra as a Non-executive Independent Director for a 5-year term (April 2025 to March 2030) and M/s Jinesh Dedhia & Associates as Secretarial Auditor for 5 years (proposed fee ₹1,30,000 for FY26). The company is also seeking shareholder approval to amend the 'Marksans Employees Stock Option Scheme 2024' to extend ESOP benefits to subsidiary company employees, covering 23 lakh ungranted stock options. E-voting will be open from August 5 (9 AM) to August 7 (5 PM), with CDSL as the e-voting platform.
For shareholders, this is a routine AGM notice — the ₹0.80 dividend is a moderate yield and the ESOP amendment to include subsidiary employees may lead to slight future dilution if exercised. No immediate stock price catalyst is expected from this filing as it is a procedural disclosure.